FDA NDC Directory · JSON-LD · Markdown

Dabigatran etexilate

NDC 43598-641 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerDr.Reddys Laboratories Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA208048
Dosage form / routeCAPSULE · ORAL
Active ingredientsDABIGATRAN ETEXILATE MESYLATE (150 mg/1)
Marketing started20250228
Package count1

External sources

Source: openFDA. Public-domain (CC0).